Onilcamotide, a cancer vaccine derived from the C-terminal peptide of the RhoC protein, exhibits potential immunomodulating and antineoplastic activities.
Molecular Weight:
2293.78
CAS Number:
[1164096-85-8]
Formula:
C96H177N39O24S
T38550
T38550
* VAT and and shipping costs not included. Errors and price changes excepted